Business
Main Life received Targretin® (Bexarotene) Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma
Main Life received Targretin® (Bexarotene) Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma GlobeNewswire July 16, 2024
![Main Life received Targretin® (Bexarotene) Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma](https://phuketnews.easybranches.com/uploads/news/2024/07/main-life-received-targretin-bexarotene-marketing-authorisation-in-hong-kong-for-cutaneous-t-cell-lymphoma.jpg)
Related
Share this page